Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shingo Takano

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
Brain Tumor Pathology|January 6, 2012
Glioblastoma angiogenesis: VEGF resistance solutions and new strategies based on molecular mechanisms of tumor vessel formationShingo Takano
Journal of Oncology|April 24, 2010
Molecular therapeutic targets for glioma angiogenesisShingo Takano, Toshiharu Yamashita, Osamu Ohneda
Brain Tumor Pathology|February 11, 2005
Angiogenesis and antiangiogenic therapy for malignant gliomasShingo Takano, Hiroshi Kamiyama, Koji Tsuboi, et al.
Neuro-Oncology|March 11, 2003
Anti-vascular endothelial growth factor antibody and nimustine as combined therapy: effects on tumour growth and angiogenesis in human glioblastoma xenograftsShingo Takano, Koji Tsuboi, Akira Matsumura, et al.
Brain Tumor Pathology|November 4, 2010
Epileptogenic glioma in a 4-year-old child: a case reportAi Muroi, Shingo Takano, Kaishi Satomi, et al.
No Shinkei Geka. Neurological Surgery|June 14, 2008
[Case report of germinoma with synchronous lesions in the thalamus and para lateral ventricle]Shingo Takano, Satoru Osuka, Ryouta Mashiko, et al.
Brain Tumor Pathology|May 12, 2021
Anti-angiogenic and macrophage-based therapeutic strategies for glioma immunotherapyEiichi Ishikawa, Tsubasa Miyazaki, Shingo Takano, et al.
No Shinkei Geka. Neurological Surgery|September 22, 2009
[Massive subarachnoid hemorrhage and intraventricular hemorrhage after transsphenoidal surgery of pituitary adenoma: a case report]Yoshiro Ito, Shingo Takano, Ai Muroi, et al.
Advances in Experimental Medicine and Biology|May 29, 2012
Adoptive cell transfer therapy for malignant gliomasEiichi Ishikawa, Shingo Takano, Tadao Ohno, et al.
Journal of Cancer Research and Clinical Oncology|December 8, 2004
Anti-angiogenic effects of SN38 (active metabolite of irinotecan): inhibition of hypoxia-inducible factor 1 alpha (HIF-1alpha)/vascular endothelial growth factor (VEGF) expression of glioma and growth of endothelial cellsHiroshi Kamiyama, Shingo Takano, Koji Tsuboi, et al.
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
Brain Tumor Pathology|January 6, 2012
Glioblastoma angiogenesis: VEGF resistance solutions and new strategies based on molecular mechanisms of tumor vessel formationShingo Takano
Journal of Oncology|April 24, 2010
Molecular therapeutic targets for glioma angiogenesisShingo Takano, Toshiharu Yamashita, Osamu Ohneda
Brain Tumor Pathology|February 11, 2005
Angiogenesis and antiangiogenic therapy for malignant gliomasShingo Takano, Hiroshi Kamiyama, Koji Tsuboi, et al.
Neuro-Oncology|March 11, 2003
Anti-vascular endothelial growth factor antibody and nimustine as combined therapy: effects on tumour growth and angiogenesis in human glioblastoma xenograftsShingo Takano, Koji Tsuboi, Akira Matsumura, et al.
Brain Tumor Pathology|November 4, 2010
Epileptogenic glioma in a 4-year-old child: a case reportAi Muroi, Shingo Takano, Kaishi Satomi, et al.
No Shinkei Geka. Neurological Surgery|June 14, 2008
[Case report of germinoma with synchronous lesions in the thalamus and para lateral ventricle]Shingo Takano, Satoru Osuka, Ryouta Mashiko, et al.
Brain Tumor Pathology|May 12, 2021
Anti-angiogenic and macrophage-based therapeutic strategies for glioma immunotherapyEiichi Ishikawa, Tsubasa Miyazaki, Shingo Takano, et al.
No Shinkei Geka. Neurological Surgery|September 22, 2009
[Massive subarachnoid hemorrhage and intraventricular hemorrhage after transsphenoidal surgery of pituitary adenoma: a case report]Yoshiro Ito, Shingo Takano, Ai Muroi, et al.
Advances in Experimental Medicine and Biology|May 29, 2012
Adoptive cell transfer therapy for malignant gliomasEiichi Ishikawa, Shingo Takano, Tadao Ohno, et al.
Journal of Cancer Research and Clinical Oncology|December 8, 2004
Anti-angiogenic effects of SN38 (active metabolite of irinotecan): inhibition of hypoxia-inducible factor 1 alpha (HIF-1alpha)/vascular endothelial growth factor (VEGF) expression of glioma and growth of endothelial cellsHiroshi Kamiyama, Shingo Takano, Koji Tsuboi, et al.
Pageof 13